National Research (NASDAQ:NRC) Stock Passes Above Two Hundred Day Moving Average – Time to Sell?

National Research Corporation (NASDAQ:NRC)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $17.54 and traded as high as $19.90. National Research shares last traded at $19.33, with a volume of 118,652 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 29th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, National Research currently has a consensus rating of “Hold”.

National Research Stock Up 1.0%

The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52. The firm has a market cap of $439.76 million, a price-to-earnings ratio of 49.56 and a beta of 0.36. The firm has a 50 day moving average price of $18.13 and a 200-day moving average price of $17.54.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.The business had revenue of $34.80 million for the quarter.

National Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $0.64 annualized dividend and a yield of 3.3%. National Research’s dividend payout ratio is presently 164.10%.

Hedge Funds Weigh In On National Research

Hedge funds have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC lifted its stake in National Research by 9,535.3% in the second quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock valued at $28,000 after buying an additional 1,621 shares during the period. Russell Investments Group Ltd. increased its holdings in shares of National Research by 85.6% in the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after acquiring an additional 921 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of National Research in the second quarter worth about $34,000. BNP Paribas Financial Markets increased its holdings in shares of National Research by 85.4% in the third quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock worth $32,000 after acquiring an additional 1,150 shares in the last quarter. Finally, Quadrant Capital Group LLC increased its holdings in shares of National Research by 315.9% in the fourth quarter. Quadrant Capital Group LLC now owns 2,583 shares of the company’s stock worth $48,000 after acquiring an additional 1,962 shares in the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.